Bristol-Myers Squibb Co. is a global biopharmaceutical company focused on discovering, developing, licensing, manufacturing, and commercializing medicines for serious diseases. Bristol-Myers Squibb Co. offers therapies across oncology, hematology, immunology, cardiovascular disease, neuroscience, and other major treatment areas, with products spanning small molecules, biologics, cell therapies, and other advanced modalities. Its portfolio includes medicines used in cancer care, autoimmune conditions, cardiovascular treatment, and selected rare or complex diseases, making the company an important supplier to hospitals, pharmacies, wholesalers, and healthcare providers worldwide. Bristol-Myers Squibb Co. operates as a major participant in the pharmaceutical market, with a business centered on prescription medicines and ongoing biopharmaceutical research, development, and distribution.